Dissociable effects of cannabis with and without cannabidiol on the human brain’s resting-state functional connectivity

Probing the endocannabinoid system in healthy volunteers: Cannabidiol alters fronto-striatal resting-state connectivity

(2018) Oliver Grimm et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

A comprehensive evaluation of increasing temporal resolution with multiband-accelerated protocols and effects on statistical outcome measures in fMRI

(2018) Lysia Demetriou et al.   NEUROIMAGE

Changes in cannabis potency and first-time admissions to drug treatment: a 16-year study in the Netherlands

(2018) Tom P. Freeman et al.   PSYCHOLOGICAL MEDICINE

Cannabis Dampens the Effects of Music in Brain Regions Sensitive to Reward and Emotion

(2017) Tom P Freeman et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Changes in Cannabis Potency Over the Last 2 Decades (1995–2014): Analysis of Current Data in the United States

(2016) Mahmoud A. ElSohly et al.   BIOLOGICAL PSYCHIATRY

LSD modulates music-induced imagery via changes in parahippocampal connectivity

(2016) Mendel Kaelen et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Keep off the grass? Cannabis, cognition and addiction

(2016) H. Valerie Curran et al.   NATURE REVIEWS NEUROSCIENCE

Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis ‘amotivational’ hypotheses

(2016) Will Lawn et al.   PSYCHOPHARMACOLOGY

Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males

(2016) C Mokrysz et al.   Translational Psychiatry

Hippocampal harms, protection and recovery following regular cannabis use

(2016) M Yücel et al.   Translational Psychiatry

Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15

(2015) Raymond J. M. Niesink et al.   ADDICTION

The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level–Dependent Resting State Functional Connectivity

(2015) Robin L. Carhart-Harris et al.   BIOLOGICAL PSYCHIATRY

Cannabis and cocaine decrease cognitive impulse control and functional corticostriatal connectivity in drug users with low activity DBH genotypes

(2015) J. G. Ramaekers et al.   Brain Imaging and Behavior

Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users

(2015) Chandni Hindocha et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Default-mode network functional connectivity is closely related to metabolic activity

(2015) Susanne Passow et al.   HUMAN BRAIN MAPPING

The CB1 Neutral Antagonist Tetrahydrocannabivarin Reduces Default Mode Network and Increases Executive Control Network Resting State Functional Connectivity in Healthy Volunteers

(2015) Ewelina Rzepa et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Examining the profile of high-potency cannabis and its association with severity of cannabis dependence

(2015) T. P. Freeman et al.   PSYCHOLOGICAL MEDICINE

phMRI: methodological considerations for mitigating potential confounding factors

(2015) Julius H. Bourke et al.   Frontiers in Neuroscience

Just say ‘know’: how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?

(2014) Tom P. Freeman et al.   ADDICTION

Emotional processing deficits in chronic cannabis use: A replication and extension

(2014) Chandni Hindocha et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The salience network is responsible for switching between the default mode network and the central executive network: Replication from DCM

(2014) Nia Goulden et al.   NEUROIMAGE

Cannabinoid Modulation of Functional Connectivity within Regions Processing Attentional Salience

(2014) Sagnik Bhattacharyya et al.   NEUROPSYCHOPHARMACOLOGY

Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms

(2013) Celia J. A. Morgan et al.   BRITISH JOURNAL OF PSYCHIATRY

Default Mode Network in the Effects of Δ9-Tetrahydrocannabinol (THC) on Human Executive Function

(2013) Matthijs G. Bossong et al.   PLoS One

Altered resting-state connectivity in adolescent cannabis users

(2013) Catherine Orr et al.   AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE

Induction of Psychosis byΔ9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing

(2012) Sagnik Bhattacharyya   ARCHIVES OF GENERAL PSYCHIATRY

Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment

(2012) Amir Englund et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Manipulating brain connectivity with δ9-tetrahydrocannabinol: A pharmacological resting state FMRI study

(2012) Linda E. Klumpers et al.   NEUROIMAGE

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

(2012) F M Leweke et al.   Translational Psychiatry

Evidence for involvement of the insula in the psychotropic effects of THC in humans: a double-blind, randomized pharmacological MRI study

(2011) Hendrika H. van Hell et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers

(2011) J Hirvonen et al.   MOLECULAR PSYCHIATRY

Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol: an fMRI Study

(2011) Toby T Winton-Brown et al.   NEUROPSYCHOPHARMACOLOGY

Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients

(2011) Mateus M Bergamaschi et al.   NEUROPSYCHOPHARMACOLOGY

Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being

(2011) C. J. A. Morgan et al.   PSYCHOLOGICAL MEDICINE

Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis

(2010) Celia JA Morgan et al.   NEUROPSYCHOPHARMACOLOGY

Toward discovery science of human brain function

(2010) B. B. Biswal et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

High-potency cannabis and the risk of psychosis

(2009) Marta Di Forti et al.   BRITISH JOURNAL OF PSYCHIATRY

Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

(2009) Sagnik Bhattacharyya et al.   NEUROPSYCHOPHARMACOLOGY

Correspondence of the brain's functional architecture during activation and rest

(2009) S. M. Smith et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Brain's Default Network

(2008) Randy L. Buckner et al.   Annals of the New York Academy of Sciences

Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis

(2008) Celia J. A. Morgan et al.   BRITISH JOURNAL OF PSYCHIATRY

Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum

(2008) Matthijs G Bossong et al.   NEUROPSYCHOPHARMACOLOGY

A critical role for the right fronto-insular cortex in switching between central-executive and default-mode networks

(2008) D. Sridharan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin

(2007) R G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY